| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/27/2002 | US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 08/27/2002 | US6440991 Ethers of 7-desmethlrapamycin |
| 08/27/2002 | US6440990 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants |
| 08/27/2002 | US6440988 Use of agonists or antagonists of the 5-HT7 receptor to treat disorders of the bladder |
| 08/27/2002 | US6440987 Antipruritic |
| 08/27/2002 | US6440985 Methods for treating viral infections |
| 08/27/2002 | US6440983 Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers |
| 08/27/2002 | US6440982 Inhibitors of cyclic guanosine monophosphate diesterases |
| 08/27/2002 | US6440981 Regulating apoptosis in human cells comprising exposing said cells to an effective amount of a 2,9-disubstituted purine-6 one compound |
| 08/27/2002 | US6440980 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/27/2002 | US6440979 Aryl isoguanines |
| 08/27/2002 | US6440978 A therapeutical agent for dermatitis comprises 7-amino-3-(halo substituted or unsubstitued benzyl)-1,2,3-tetrahydro-1-phenylpyrido(2,3-d)pyrimidin-2,4-dione |
| 08/27/2002 | US6440976 Iminopyrimidine NMDA NR2B receptor antagonists |
| 08/27/2002 | US6440975 Amino acid derivatives, the preparation and use thereof as endothelin antagonists |
| 08/27/2002 | US6440973 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
| 08/27/2002 | US6440972 Heterocyclic compounds useful as oxido-squalene cyclase inhibitors |
| 08/27/2002 | US6440971 Binuclear complex |
| 08/27/2002 | US6440969 Certain isoquinolinamine and phthalazinamine derivatives: corticotropin-releasing factor receptor CRF1 specific ligands |
| 08/27/2002 | US6440968 Use of maduraohtalazine derivatives as inhibitors of proinflammatory cytokines |
| 08/27/2002 | US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors |
| 08/27/2002 | US6440965 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 08/27/2002 | US6440964 Containing antibiotics such as moxifloxacin; treating infections of microbacterium species microbacterium otitidis and microbacterium alconae |
| 08/27/2002 | US6440963 Use of selective COX-2 inhibitors for the treatment of urinary incontinence |
| 08/27/2002 | US6440962 Cardiovascular disorders, antiischemic agents |
| 08/27/2002 | US6440961 Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 08/27/2002 | US6440960 An oxygen or sulfure or sulfure oxide or dioxide containing tricyclic compouund useful for treating the disorder manifesting hypersecretion of corticotropin releasing factor |
| 08/27/2002 | US6440959 Inhibitors of cyclin-dependent kinases |
| 08/27/2002 | US6440958 Acrylic and propionic acid compounds, intermediates, processes, compositions, and methods |
| 08/27/2002 | US6440957 Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 08/27/2002 | US6440955 Anti-inflammatory agents |
| 08/27/2002 | US6440954 Inhibition of vascular smooth muscle cell proliferation |
| 08/27/2002 | US6440953 Use as an anti-cancer agent and for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion. |
| 08/27/2002 | US6440952 Phosphono-carboxylate compounds for treating amyloidosis |
| 08/27/2002 | US6440951 Method for treatment of diabetes |
| 08/27/2002 | US6440949 Method for promoting the growth of gram-positive bacilli and increasing the acidity in vagina |
| 08/27/2002 | US6440948 Thiophene A2A receptor agonists |
| 08/27/2002 | US6440947 Coadministration of an adenosine a2 receptor agonist, e.g., adenosine and heparin or heparin-like compound to improve collateral coronary circulation in patients suffering from myocardial infarction; angiogenisis |
| 08/27/2002 | US6440943 Mimic and/or modulate the activity of wild-type nucleic acids; the 5' and the 3'-terminal internucleoside linkages are chirally sp and internal internucleoside linkages are chirally rp; resistant to nuclease degradation; psoriasis |
| 08/27/2002 | US6440941 Derivatives of erythromycin, their preparation process and their use as medicaments |
| 08/27/2002 | US6440938 Prevention and/or treatment of allergic conditions |
| 08/27/2002 | US6440937 Competitive inhibitors of trypsin-like serin proteases, especially thrombin and kininogenases such as kallikrein; thrombin inhibitors, anticoagulants, and antiinflammatory agents |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440931 Conjugated linoleic acid in treatment and prophylaxis of diabetes |
| 08/27/2002 | US6440929 Pulmonary delivery of active agents |
| 08/27/2002 | US6440749 Administering a thiazole compound |
| 08/27/2002 | US6440743 Supplying immobilizated polynucleotides |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440691 Melanins with improved ability to inhibit HIV replication |
| 08/27/2002 | US6440465 Topical composition for the treatment of psoriasis and related skin disorders |
| 08/27/2002 | US6440463 Methods for fine powder formation |
| 08/27/2002 | US6440462 Agglomerates of β-lactam antibiotics and processess for making agglomerates |
| 08/27/2002 | US6440458 Solid solution of tacrolimus or hydrate and hydroxypropyl cellulose |
| 08/27/2002 | US6440457 Administering venlafaxine antidepressant time-release agent; sustained release |
| 08/27/2002 | US6440455 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 08/27/2002 | US6440454 Supersaturated solution of estradiol, progestogen, and activated silica; outer backing foil and protective lining |
| 08/27/2002 | US6440453 Transdermal systems for release of 5-HT3 receptor antagonists and their use in anti-emetic treatment |
| 08/27/2002 | US6440448 Plant and/or animal extract, antioxidant, orally ingestible carrier; antitumor and anticarcinogenic agents; aging resistance; storage stability |
| 08/27/2002 | US6440446 Agent for anti-osteoporosis |
| 08/27/2002 | US6440442 Hydrophilic polymer blends used for dry cow therapy |
| 08/27/2002 | US6440428 Podophyllotoxin preparation containing triglycerides |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440419 J chain or portion thereof linked to at least one enzyme inhibitor; specifically binds to basolateral factor; eradi-cation of metastatic or nonpolarized cells; lung, breast, colon, ovarian and prostate carcinoma and endometriosis |
| 08/27/2002 | US6440418 Variable light and heavy amino acid sequences encoded by nucleic acid sequences; seq id no:24, 25 and 26; rheumatoid arthritis, multiple sclerosis, diabetes, and systemic lupus erythematosus; graft versus host disease; gene therapy |
| 08/27/2002 | US6440416 Primate antiidiotype antibody or fragment acting as immuno-genic functional mimic; preventive or therapeutic immune response against tumors, viruses, bacteria, rickettsia, mycoplasma, protozoa, fungi and multicellular parasites |
| 08/27/2002 | US6440413 Selectively destroying subunit a without destroying subunit b of cholera toxin; enzyme with preponderance of exocellular proteinase produced by a culture of streptomyces fradiae; hyperviscosity of intestinal, bronchial and/or genital mucus |
| 08/27/2002 | US6440410 Normalizing cholesterol and blood pressure; administering natural antioxidant phytochemicals found in fruits and vegetables, including polyphenols, such as chlorogenic acid and ellagic acid, and an enzyme mixture |
| 08/27/2002 | US6440405 Quaternary ammonium functionalized dendrimers and methods of use therefor |
| 08/27/2002 | US6440393 Sdministering aerosolized drug in an air mixture containing up to about 10% carbon dioxide gas for increasing the deposition of aerosolized drug in the respiratory tract of an individual or animal |
| 08/27/2002 | US6440391 Management of snoring by oral administration of dimethyl sulfone |
| 08/27/2002 | US6440387 For decreasing blood cholesterol levels, thereby decreasing risk for developing alzheimer's disease; for post menopausal women |
| 08/27/2002 | CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
| 08/27/2002 | CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/27/2002 | CA2140013C Pharmaceutical compositions containing galactosylceramides |
| 08/27/2002 | CA2125888C Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
| 08/27/2002 | CA2108898C Blended carboxylic acid sanitizer |
| 08/27/2002 | CA2104795C 1-arylheteroarylalkyl substituted-1h-1,2,4-triazole compounds for treatment of circulatory disorders |
| 08/27/2002 | CA2101548C Acylamino-alkylidenhydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases |
| 08/27/2002 | CA2085354C Ether lipid-nucleoside covalent conjugates |
| 08/27/2002 | CA2078019C Substance or composition and uses thereof |
| 08/27/2002 | CA2065889C Increasing the choroidal blood flow |
| 08/27/2002 | CA2062837C 8-substituted purines as selective adenosine receptor agents |
| 08/27/2002 | CA2045955C Indole derivatives |
| 08/27/2002 | CA2033392C A-nor-steroid-3-carboxylic acid derivatives |
| 08/27/2002 | CA2032311C 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase and 19-hydroxylase inhibitors |
| 08/27/2002 | CA2025703C Pulsatile once-a-day delivery systems for minocycline |
| 08/27/2002 | CA2015838C Method of topically treating acne vulgaris |
| 08/26/2002 | CA2373363A1 Antitumor and antiviral medications and method for producing the same |
| 08/22/2002 | WO2002064832A1 Method of examining allergic disease |
| 08/22/2002 | WO2002064809A2 Process for the preparation of one or more statins by fermentation |
| 08/22/2002 | WO2002064791A2 Proteins and nucleic acids encoding same |
| 08/22/2002 | WO2002064790A2 Jfy1 protein induces rapid apoptosis |
| 08/22/2002 | WO2002064788A2 Compositions and methods relating to lung specific genes and proteins |
| 08/22/2002 | WO2002064766A2 Bax-responsive genes for drug target identification in yeast and fungi |
| 08/22/2002 | WO2002064735A2 Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 |
| 08/22/2002 | WO2002064731A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/22/2002 | WO2002064635A1 2-alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 08/22/2002 | WO2002064618A2 Methods of identifying agents that mediate polypeptide aggregation |
| 08/22/2002 | WO2002064616A2 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | WO2002064613A1 Genetic therapeutics for obesity and diabetes by targeting cathepsin |